Embecta Corp.

EMBC · XNAS

CIK 1872789fmd_0EBP7G03J5FVG3DPZFBB9EV5JEManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Oct 01, 2019 to Jun 30, 2026, 24 periods

Income Statement · Annual · Millions · USD
Line item	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	1,086	1,165	1,130	1,121	1,123	1,080
Cost of revenue	323	365	355	371	388	404
Gross profit	763	800	775	750	735	677
Research and development	61	63	67	85	79	37
Selling, general and administrative	215	240	295	341	365	332
Total operating expenses	276	308	465	528	568	435
Operating income	487	492	310	222	167	242
Other non-operating income (expense)	(1)	3	(7)	(9)	(10)	2
Income before taxes	486	495	257	106	44	136
Income tax expense	58	80	33	35	(34)	41
Net income from continuing operations	428	415	224	70	78	95
Net income	428	415	224	70	78	95